Insulet
PODD
#1049
Rank
NZ$31.49 B
Marketcap
$448.96
Share price
-1.72%
Change (1 day)
49.91%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): NZ$0.49 Billion

According to Insulet's latest financial reports the company's current earnings are NZ$1.87 Billion. In 2023 the company made an earning of NZ$0.42 Billion, an increase over its 2022 earnings that were of NZ$73.85 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.49 B16.31%
2023 NZ$0.42 B481.9%
2022 NZ$73.85 M-45.24%
2021 NZ$0.13 B43.35%
2020 NZ$94.07 M18.51%
2019 NZ$79.38 M41.16%
2018 NZ$56.23 M-711.95%
2017 -NZ$9.2 Million-56.85%
2016 -NZ$21.31 Million-79.31%
2015 -NZ$0.11 Billion63.85%
2014 -NZ$62.84 Million31.04%
2013 -NZ$47.96 Million-21.96%
2012 -NZ$61.46 Million
2010 -NZ$58.61 Million-42.38%
2009 -NZ$0.11 Billion-33.56%
2008 -NZ$0.16 Billion65.93%
2007 -NZ$92.27 Million209.75%
2006 -NZ$29.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$12.58 M-97.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.24 Billion-144.47%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.30 B 149.07%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$31.52 B 5,905.55%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$11.61 B 2,112.86%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$9.67 B 1,742.96%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$17.39 B 3,213.91%๐Ÿ‡บ๐Ÿ‡ธ USA